Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Orgeon Health & Science University
mi
from
Portland, OR
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Orgeon Health & Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Albert Einstein Medical Center
mi
from
Philadelphia, PA
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Albert Einstein Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Univ of Pennsylvania
mi
from
Philadelphia, PA
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Temple University Hospital
mi
from
Philadelphia, PA
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Drexel University College of Medicine
mi
from
Philadelphia, PA
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
VA Pittsburgh Healthcare System
mi
from
Pittsburgh, PA
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
VA Pittsburgh Healthcare System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
WJB Dorn VA Medical Center
mi
from
Columbia, SC
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
WJB Dorn VA Medical Center
mi
from
Columbia, SC
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Vanderbilt Medical Center
mi
from
Nashville, TN
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Vanderbilt Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Baylor University Medical Center
mi
from
Dallas, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
U.T. Southwestern Medical Center
mi
from
Dallas, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Dallas VA Medical Center
mi
from
Dallas, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
University of Texas Medical Branch at Galveston
mi
from
Galveston, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
University of Texas Medical Branch at Galveston
mi
from
Galveston, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
St. Luke's Advanced Liver Therapies
mi
from
Houston, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
St. Luke's Advanced Liver Therapies
mi
from
Houston, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Houston Methodist Hospital
mi
from
Houston, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
University of Texas Health Science Center at Houston/Memorial Hermann Hospital
mi
from
Houston, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
University of Texas Health Science Center at Houston/Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Methodist Specialty Transplant Hospital Lab
mi
from
San Antonio, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Methodist Specialty Transplant Hospital Lab
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
University of Texas Health Science Center
mi
from
San Antonio, TX
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
University of Utah
mi
from
Salt Lake City, UT
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Virginia Commonwealth University Health System
mi
from
Richmond, VA
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Virginia Commonwealth University Health System
mi
from
Richmond, VA
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Mcguire Dvamc
mi
from
Richmond, VA
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Mcguire Dvamc
mi
from
Richmond, VA
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
Virginia Mason Medical Center
mi
from
Seattle, WA
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated:  2/1/2013
University of Wisconsin
mi
from
Madison, WI
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Phase 3, Multi-Center Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Lucassin® (Terlipressin) (REVERSE Trial)
Status: Enrolling
Updated: 2/1/2013
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates
The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates
Status: Enrolling
Updated:  2/6/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates
The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates
Status: Enrolling
Updated: 2/6/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Protocol to Assess the Severity of Acute Kidney Injury
Protocol to Assess the Severity of Acute Kidney Injury
Status: Enrolling
Updated:  2/8/2013
George Washington University Hospital
mi
from
Washington,
Protocol to Assess the Severity of Acute Kidney Injury
Protocol to Assess the Severity of Acute Kidney Injury
Status: Enrolling
Updated: 2/8/2013
George Washington University Hospital
mi
from
Washington,
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Santa Clara, CA
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Washington,
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Coeur D Alene, ID
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Coeur D Alene, ID
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Park Ridge, IL
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Metairie, LA
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Baltimore, MD
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Rochester, MN
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Helena, MT
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Helena, MT
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
New York, NY
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Ashville, NC
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Cleveland, OH
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Portland, OR
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Philadelphia, PA
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Chattanooga, TN
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Dallas, TX
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Norfolk, VA
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
The Impact of Nebivolol Versus Metoprolol on Quality of Life
The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients
Status: Enrolling
Updated:  2/14/2013
Brigham and Women's Hosp
mi
from
Boston, MA
The Impact of Nebivolol Versus Metoprolol on Quality of Life
The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients
Status: Enrolling
Updated: 2/14/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
The Impact of Nebivolol Versus Metoprolol on Quality of Life
The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients
Status: Enrolling
Updated:  2/14/2013
Lahey Clinic
mi
from
Burlington, MA
The Impact of Nebivolol Versus Metoprolol on Quality of Life
The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients
Status: Enrolling
Updated: 2/14/2013
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
APOL1 Gene Variants in African American Kidney Transplant Recipients
Impact of APOL1 Gene Variants in African American Kidney Transplant Recipients: A Study of Clinical Outcomes and Molecular Mechanisms
Status: Enrolling
Updated:  2/14/2013
Brigham and Women's Hosp
mi
from
Boston, MA
APOL1 Gene Variants in African American Kidney Transplant Recipients
Impact of APOL1 Gene Variants in African American Kidney Transplant Recipients: A Study of Clinical Outcomes and Molecular Mechanisms
Status: Enrolling
Updated: 2/14/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Navigating the Challenges of Chronic Kidney Disease
Navigating the Challenges of Chronic Kidney Disease
Status: Enrolling
Updated:  2/14/2013
Cleveland Clinic
mi
from
Cleveland, OH
Navigating the Challenges of Chronic Kidney Disease
Navigating the Challenges of Chronic Kidney Disease
Status: Enrolling
Updated: 2/14/2013
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cidofovir in Renal Transplant Recipients With BKVN
A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy
Status: Enrolling
Updated:  2/28/2013
University of Alabama Hospital - Nephrology
mi
from
Birmingham, AL
Cidofovir in Renal Transplant Recipients With BKVN
A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy
Status: Enrolling
Updated: 2/28/2013
University of Alabama Hospital - Nephrology
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cidofovir in Renal Transplant Recipients With BKVN
A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy
Status: Enrolling
Updated:  2/28/2013
California Pacific Medical Center - Sutter Pacific Medical Foundation - Transplant Nephrology
mi
from
San Francisco, CA
Cidofovir in Renal Transplant Recipients With BKVN
A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy
Status: Enrolling
Updated: 2/28/2013
California Pacific Medical Center - Sutter Pacific Medical Foundation - Transplant Nephrology
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cidofovir in Renal Transplant Recipients With BKVN
A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy
Status: Enrolling
Updated:  2/28/2013
University of California San Francisco Medical Center at Parnassus - Organ Transplant
mi
from
San Francisco, CA
Cidofovir in Renal Transplant Recipients With BKVN
A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy
Status: Enrolling
Updated: 2/28/2013
University of California San Francisco Medical Center at Parnassus - Organ Transplant
mi
from
San Francisco, CA
Click here to add this to my saved trials